{
    "nctId": "NCT05280288",
    "briefTitle": "Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer",
    "officialTitle": "Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer - a Non-inferiority 2-year Randomized Controlled Trial (The BELIEVE@BC -Better Life Even After Breast Cancer Study)",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Early-stage Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Changes in Quality of life measured by the European Organization for Research and Treatment of Cancer Quality of Life",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal women\n* Age 50-70 years\n* Danish speaking\n* Diagnosed with EBC, stage I-III\n* Eligible to receive (neo-) adjuvant chemotherapy or adjuvant treatments\n* Access to an E-mail address\n* Access to smart mobile electronic devices connected to the internet\n* Willingness to have the app installed on the smart mobile electronic devices\n* Ability to work with the app\n\nExclusion Criteria:\n\n* Prior malignancy\n* Pre-existing type 2 diabetes or other metabolic diseases\n* Withdrawn or not given a consent form",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}